Olympian Clinical Research
Olympian Clinical Research is a Tampa-based clinical research site conducting Phase I-IV trials in dermatology and other therapeutic areas for pharma sponsors and CROs, leveraging affiliation with Academic Alliance in Dermatology's 150,000+ patient database.
- Company typePrivate
- Founded2007
- HeadquartersTampa, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Olympian Clinical Research does
Olympian Clinical Research is a privately held clinical research site founded in 2007 in Tampa, Florida by Dr. Panos Vasiloudes. It conducts Phase I–IV clinical trials (primarily Phase II and III) for both adult and pediatric patients across dermatological indications — atopic dermatitis, hidradenitis suppurativa, chronic spontaneous urticaria, plaque psoriasis, alopecia areata, vitiligo — and non-dermatological indications including endometriosis, migraines, depression, Alzheimer's disease, schizophrenia, OCD, and fibromyalgia.
The company operates three physical office locations in the Tampa Bay area (Tampa headquarters, Clearwater, and Saint Petersburg) and is strategically affiliated with Academic Alliance in Dermatology, a 16-office dermatology practice group with 20 providers and a database of more than 150,000 patients that serves as the primary recruitment backbone for OCR's dermatology trials. Participant-facing services include free study-related care and medication, stipends for time and travel, and a Refer-a-Friend recruitment program; sponsor/CRO-facing services include protocol execution, data collection, and regulatory compliance under FDA-sponsored studies.
OCR generates revenue by performing clinical trial conduct services for pharmaceutical sponsors and Contract Research Organizations, receiving compensation for participant recruitment, study execution, and regulatory deliverables. Its go-to-market is community-led: patients are recruited through the affiliated AAD database, community outreach, referral programs, and an educational content-marketing blog, while sponsor relationships are pursued through direct outreach to CROs and pharma. The company is a MAGI Blue Ribbon Site Charter Member and remains founder-led, with no disclosed external institutional investment.
Olympian Clinical Research firmographics
Firmographics- Name
- Olympian Clinical Research
- Legal name
- Olympian Clinical Research
- Website
- https://olympianresearch.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Olympian Clinical Research is a Tampa-based clinical research site conducting Phase I-IV trials in dermatology and other therapeutic areas for pharma sponsors and CROs, leveraging affiliation with Academic Alliance in Dermatology's 150,000+ patient database.
- Ownership category
- akta.pro rank
Olympian Clinical Research industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
- akta.pro secondary industry
- Psoriasis & Eczema Specialty Care (HLAKACAL)
Keywords
Where Olympian Clinical Research is headquartered
LocationHeadquarters
- HQ city
- Tampa
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Olympian Clinical Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Clinical Trial Conduct Services: Olympian Clinical Research generates revenue by conducting clinical trials on behalf of pharmaceutical sponsors and Contract Research Organizations (CROs). They receive compensation for participant recruitment, study execution, data collection, and regulatory compliance. Study-related care and medications are provided at no cost to participants, with participants receiving stipends for time and travel.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Olympian Clinical Research product offering
Product offeringCore offering
Olympian Clinical Research is a clinical research site network that conducts Phase I–IV clinical trials for pharmaceutical and biotechnology sponsors, with specialization in Phase II and III dermatology studies (e.g., atopic dermatitis, psoriasis, hidradenitis suppurativa, chronic spontaneous urticaria, prurigo nodularis) and selected non-dermatology indications. The company recruits and retains study participants, performs protocol-driven assessments by board-certified specialists drawn from its affiliate Academic Alliance in Dermatology, and supplies sponsors and CROs with regulatory-grade clinical data across adult and pediatric populations.
Product overview
Olympian Clinical Research operates as a clinical research organization offering Phase I-IV clinical trials primarily in Phase II & III for both adult and pediatric patients. The company conducts FDA-sponsored clinical research studies across two main areas: dermatological conditions (including atopic dermatitis, hidradenitis suppurativa, chronic spontaneous urticaria, plaque psoriasis, vitiligo, and alopecia areata) and non-dermatological conditions (including endometriosis, depression, migraines, Alzheimer's disease, and other systemic disorders). The organization provides study-related care, medication at no cost, and compensation for time and travel to eligible participants. Additional services include a patient referral program and pre-screening intake paperwork. Founded in 2007 and affiliated with Academic Alliance in Dermatology, the company has 16 offices across the Tampa area with access to over 150,000 patients.
Differentiator
Problem solved
Functional benefit
Products and services
- Phase I–IV Clinical Trial Site Services Site-based clinical trial execution for pharmaceutical and biotechnology sponsors across all clinical phases, with specialist depth in Phase II and III, including protocol-driven recruitment, consent, dosing visits, assessments, and regulatory-grade data collection for adult and pediatric participants.
- Dermatology Clinical Trials Site-based Phase I–IV dermatology clinical trials for indications including atopic dermatitis, chronic spontaneous urticaria, hidradenitis suppurativa, plaque psoriasis, prurigo nodularis, and acne, evaluating investigational therapies on behalf of pharmaceutical sponsors and CROs.
- Non-Dermatology Clinical Trials Site-based Phase I–IV clinical trials conducted outside the dermatology specialty, covering selected indications such as osteoarthritis, chronic kidney disease, and hyperlipoproteinemia, delivered for pharmaceutical sponsors using the same site infrastructure and recruitment database.
- Healthy Patient/Volunteer Studies Site-conducted clinical trials enrolling healthy adult and pediatric volunteers for pharmacokinetic, safety, and bioequivalence studies contracted by sponsors and CROs.
- Pediatric Clinical Trials Age-appropriate site-based clinical trial conduct for pediatric populations across qualifying dermatology and healthy-volunteer studies, including parental-consent workflows and pediatric-specific dosing assessments.
Companies that use Olympian Clinical Research
Customer profileSegments2 records
Ideal customer profiles2 records
Olympian Clinical Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Olympian Clinical Research partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Academic Alliance in DermatologycoreOlympian Clinical Research is affiliated with Academic Alliance in Dermatology, a dermatology practice group with 16 offices in the Tampa area, 20 providers, and a database of over 150,000 patients. This affiliation provides the primary patient recruitment channel and clinical infrastructure for conducting clinical trials.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Olympian Clinical Research competitors and assessment
Company assessmentDirect peers
- Pinnacle Clinical Research: Dermatology-focused clinical research site network with multi-location enrollment for inflammatory skin disease trials. Comparable due to single-therapeutic focus on dermatology, parallel sponsor base, and similar Phase II/III protocol mix.
- Elligo Health Research: Hybrid decentralized clinical research site network combining dedicated research sites with community-based physician partnerships for patient recruitment. Comparable because both organizations leverage affiliated physician/clinical databases to enroll trial participants.
- Accel Research Sites: Multi-specialty clinical research site network operating across several U.S. states with a Phase I–IV trial portfolio for sponsors. Closely comparable in business model (multi-site contract research services) and recruiting model (database-driven enrollment).
- Meridien Research: Florida-based clinical research site network with multiple locations across the Tampa Bay and central Florida region, running Phase II–IV trials in dermatology and other specialties. Highly comparable given shared Florida geography and overlapping dermatology and chronic-condition trial mix.
- Research Across America: Independent multi-specialty clinical trial site group operating Phase II–IV studies across therapeutic areas including dermatology. Directly comparable as a similarly sized independent site network serving the same sponsor and CRO customer base.
- Velocity Clinical Research: Multi-site clinical research organization operating a network of dedicated research centers across the U.S. that conduct Phase I–IV trials for pharmaceutical sponsors and CROs, directly comparable to Olympian's model of multi-site Phase II/III trial conduct.
Broad incumbents
- PMG Research: Established multi-site clinical research network (now part of a larger CRO platform) that operates dedicated research sites across the U.S. Comparable as a broader, better-capitalized incumbent offering sponsors the multi-region site coverage Olympian currently lacks.
- Clario: Large clinical research services and technology provider offering data, endpoint, and site-supporting services to pharmaceutical sponsors running trials. Comparable as a broader incumbent in clinical research services whose offerings intersect with the operational needs of PI-led sites.
- IQVIA: Global CRO and clinical research services provider that owns and operates site networks in addition to its core CRO business. Relevant as both a customer of independent sites (sponsor/CRO counterparty) and as a competitor that could absorb regional sites into its integrated network.
Emerging players
- Flourish Research: Multi-site clinical research organization built by consolidating independent research sites, running Phase I–IV trials across several U.S. regions. Comparable in operating model and as a likely competitive consolidator of independent sites like Olympian.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Olympian Clinical Research social profiles
Digital presenceOlympian Clinical Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
Olympian Clinical Research leadership team
Management profileNumber of profiles
Profiles1 record
Olympian Clinical Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Olympian Clinical Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Olympian Clinical Research
What does Olympian Clinical Research do?
Olympian Clinical Research is a clinical research site network that conducts Phase I–IV clinical trials for pharmaceutical and biotechnology sponsors, with specialization in Phase II and III dermatology studies (e.g., atopic dermatitis, psoriasis, hidradenitis suppurativa, chronic spontaneous urticaria, prurigo nodularis) and selected non-dermatology indications. The company recruits and retains study participants, performs protocol-driven assessments by board-certified specialists drawn from its affiliate Academic Alliance in Dermatology, and supplies sponsors and CROs with regulatory-grade clinical data across adult and pediatric populations.
Is Olympian Clinical Research a public or private company?
Olympian Clinical Research is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Olympian Clinical Research founded?
Olympian Clinical Research was founded in 2007. It employs 11 to 50 people.
Where is Olympian Clinical Research based?
Olympian Clinical Research is headquartered in Tampa, United States, in the North America region.
How does Olympian Clinical Research make money?
One revenue line is on record: clinical Trial Conduct Services.
Who are Olympian Clinical Research's main competitors?
Direct peers on record are Pinnacle Clinical Research, Elligo Health Research, Accel Research Sites, Meridien Research, Research Across America and Velocity Clinical Research. Broad incumbents are PMG Research, Clario and IQVIA. Flourish Research is listed as an emerging player.
Does Olympian Clinical Research have an API?
No public API is recorded for Olympian Clinical Research.
What industry is Olympian Clinical Research in?
Olympian Clinical Research's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAKACAL, Psoriasis & Eczema Specialty Care. Its NAICS code is 5417 and its SIC code is 8093.